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Abstract
Background: Severe Acute Respiratory Syndrome (SARS) is a severe respiratory illness caused by a novel virus, the
SARS coronavirus (SARS-CoV). 3C-like protease (3CLpro) of SARS-CoV plays a role in processing viral polypeptide
precursors and is responsible of viral maturation. However, the function of 3CLpro in host cells remains unknown.
This study investigated how the 3CLpro affected the secretion of cytokines in the gene-transfected cells.
Results: From immunofluorescence microscopy, the localization of c-myc tagged 3CLpro was detected both in the
cytoplasm and nucleus of transfected A549 cells. Expression of granulocyte-macrophage colony-stimulating factor
(GM-CSF) was significantly decreased in 3CLpro-transfected cells by both RT-PCR and ELISA, but without changes in
other cytokines, i.e., IL-1b, IL-6, IL-8, IL12p40, TNF-a, and TGF-b. Furthermore, the protein levels of NF-kB decreased
in 3CLpro-transfected A549 cells when compared to EGFP transfected cells.
Conclusions: Our results suggest that the 3CLpro may suppress expression of GM-CSF in transfected A549 cells
through down-regulation of NF-kB production.
Background
Severe acute respiratory syndrome (SARS) emerged as a
communicable human disease in November 2002 and
rapidly spread throughout the world [1]. A coronavirus,
called SARS-associated coronavirus (SARS-CoV), was
identified as the causative agent [2,3]. SARS-CoV is a
plus-strand RNA virus featuring a large single-stranded
RNA genome of approximately 29.7 kb [4] that contains
16 non-structural proteins (nsps) with multiple enzy-
matic functions. These are known or are predicted to
include types of enzymes that are common components
of the replication machinery of plus-strand RNA viruses
[5,6]. In these nsps, the Nsp5 [main protease (Mpro) or
3C-like protease (3CLpro)] is responsible for the proteo-
lytic processing of viral polypeptides into functional pro-
teins and 3CLpro mutant, C145A, blocks the maturation
process [7]. This viral protease has been the target for
design of the inhibitors [7-11]. Recently, SARS-3CLpro
was found to induce cell apotosis and interact with cel-
lular vacuolar-H+ ATPase [12,13]. Several human pro-
teins might possess a similar structure of SARS-3CLpro
cleavage sites using computational methods [14]. Theses
studies implied the SARS-3CLpro could involve in virus-
induced host pathology.
SARS-CoV causes a severe lung infection, and the
epithelial cells of the upper respiratory tract are the pri-
mary targets [15-17]. SARS-CoV reproduces rapidly and
causes massive cell damage. At the whole-body level,
immune-mediated damage, due to activation of cyto-
kines and/or chemokines [18-22] and, perhaps, autoim-
munity [23,24], may play key roles in the clinical and
pathological features of SARS. One of the major causes
of host death is the induction of lung fibrosis. The
mechanism of the lung fibrosis caused by SARS-CoV
requires elucidation. Significant efforts have been made
to analyze the function of SARS-3CLpro on viral replica-
tion, but the impact of SARS-3CLpro on cytokines of the
host cell is still unclear. In this study, we constructed
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the pEGFP-C3 vector with SARS-3CLpro gene and trans-
fected it into A549 lung epithelial cells. The expression
profiles of cytokines were validated by RT-PCR and
ELISA. The results indicated that the expression and
secretion of granulocyte-macrophage colony-stimulating
factor (GM-CSF) decrease in SARS-3CLpro transfected
A549 cells. Furthermore, NF-kB, putative regulators of
GM-CSF gene expression, was also decreased on its pro-
tein level in 3CLpro transfected cells.
Results
Construction of SARS-CoV 3CLpro wild type and a mutant
C145A clone into pEGFP-C3 vector
To optimize the efficiency of transfection and expression
of functional 3CLpro in A549 lung cancer cell line, we con-
structed expression vector expressing SARS-CoV 3CLpro
wild type gene into a pEGFP-C3 vector (Figure 1A). An
inactive 3CLpro mutant, C145A (TGT®GCT), was also
included in this study as a negative control [7]. Further-
more, the myc tag sequence was also introduced into the
3’ end of the 3CLpro and C145A genes for immunofluores-
cence analysis. The DNA fragments of CMV promoter,
3CLpro wild type, and C145A 3CLpro mutant were ampli-
fied by PCR using primers containing restriction enzyme
sites as shown in Figure 1A. The expression constructs
were further verified by 1% agarose gel electrophoresis
after restriction enzymes digestion (Figure 1B). As
expected, the 597 bp of PCMV and 956 bp of 3CLpro (and
C145A) fragments were excised from plasmids with
appropriate restriction enzymes and were confirmed by
DNA sequencing.
Expression of EGFP, 3CLpro, and C145A in A549 cells
The plasmids of pEGFP-C3, pEGFP-3CLpro, and pEGFP-
C145A were successfully transfected into A549 cells
respectively. The expression levels of 3CLpro and C145A
mRNA were determined by reverse transcription (RT)-
PCR and the protein expression levels were analyzed
using 2D western blots (Figure 2A and 2B). The results
indicated that the expression of 3CLpro and C145A
mRNA reached the highest level in A549 cells at 12 to
24 hrs and slightly decreased their expression at 48 h
after transfection. However, 2D western blots results
indicated that the protein expression levels of 3CLpro
and C145A steadily increased with time up to 48 hrs
after transfection. To track the locations of 3CLpro and
C145A proteins in transfected A549 cells, Myc-tagged
3CLpro and C145A were detected using rhodamine-
conjugated anti-Myc antibodies. The immunofluores-
cence microscopic images demonstrated 60-70% trans-
fection efficiency (data not shown) and the localizations
of c-myc tagged 3CLpro and C145A were detected both
in the cytoplasm and nucleus of transfected A549 cells
compared to control EGFP (Figure 3).
The expression of GM-CSF in SARS-3CLpro transfected
A549 cells by semi-quantification RT-MPCR
Total RNA from A549 cells (C), EGFP (E) and pEGFP-
3CLpro (3CLpro) transfected cells were collected at 12,
24, 48, and 72 hrs. As shown in Figure 4, expression of
GM-CSF was demonstrated in 3CLpro transfected cells,
A549 cells and EGFP transfected cells (Figures 2A and
4A) by Multiplex PCR kits. The decreased percentage
















Figure 1 Construction of pEGFP-3CLpro and pEGFP-C145A
expression vectors. (A) Scheme of pEGFP-3CLpro and pEGFP-C145A
construction. PCMV, human cytomegalovirus (CMV) immediate early
promoter; EGFP, enhanced green fluorescent protein gene; MCS,
multiple cloning sites; 3CLpro, SARS-CoV 3CLpro gene; C145A, 3CLpro
C145A mutant gene; myc, myc-tag sequence; pA, SV40 early mRNA
polyadenylation signal sequence. (B)The constructs were digested
with restriction enzyme and separated on 1% agarose gel. M, DNA
markers.
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Figure 2 RT-PCR and 2-D western blot analysis of EGFP, 3CLpro, and C145A transfected A549 cell line. (A) RT-PCR analysis of 3CLpro and
GM-CSF genes expression at 12, 24, and 48 hrs in A549 cells which were transfected with EGFP, 3CLpro, and C145A respectively. The relative
abundance compared with the expression level of GAPDH is depicted in the bar chart below. (B) 2-D western blots of 3CLpro and C145A
expression patterns in A549 cells. A549 cells transfected with EGFP, 3CLpro and C145A were analyzed at 24 and 48 hrs after transfection. Proteins
were resolved by 2-D gels and electroblotted onto PVDF membranes. Western blots were probed with anti-3CLpro specific antibody. The circle
indicates the site of 3CLpro.
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compared to the EGFP transfected A549 cells at 6, 12, 24,
48, and 72 hrs is 9%, 17%, 25%, 49%, and 56%, respec-
tively. There was significant decrease of GM-CSF in
3CLpro transfected A549 cells after 24 hrs (p < 0.005).
Additionally, there were no change to the mRNA expres-
sion of IL-1b, IL-6, IL-8, IL12p40, TNF-a, and TGF-b
found in 3CLpro transfected cells. To confirm the mRNA
expression of GM-CSF, other primer pairs were used to
amplify GM-CSF by semi-quantification RT-MPCR. As
shown in Figure 4B, decreased expression of GM-CSF
was noted in 3CLpro transfected cells compared to
GAPDH in A549 cells and EGFP transfected cells at 24,
48, and 72 hrs. A significant decrease of GM-CSF was
observed in 3CLpro transfected A549 cells after 24, 48,
and 72 hrs with maximal reduction folds of vector con-
trol about 0.75, 0.53 and 0.45, respectively (p < 0.005).
The secretion of GM-CSF in SARS-3CLpro transfected A549
cells by ELISA
As shown in Figure 5, the values of GM-CSF concentra-
tion in the culture mediums of EGFP transfected A549
cells at 6, 12, 24, 48, and 72 hrs were 2.047 ± 0.2(pg/ml),
9.928 ± 0.13(pg/ml), 11.657 ±.15 (pg/ml), 60.714 ±.0.18
(pg/ml), 88.926 ±.0.31 (pg/ml), respectively. The values of
GM-CSF concentration in the culture mediums of 3CLpro
transfected A549 cells at 6, 12, 24, 48, and 72 hrs were
2.624 ± 0.13(pg/ml), 6.852 ± 0.17(pg/ml), 7.237 ±.0.11 (pg/
ml), 37.313 ±.0.18 (pg/ml), 56.25 ±.0.31 (pg/ml), respec-
tively. The values of GM-CSF concentration in the culture
mediums of C145A transfected A549 cells at 6, 12, 24, 48,
and 72 hrs were 4.431 ± 0.11(pg/ml), 14.424 ± 0.21
(pg/ml), 22.281 ±.0.54 (pg/ml), 66.235 ±.0.68 (pg/ml),
85.715 ±.0.43 (pg/ml), respectively. A significant decrease
of GM-CSF was observed in 3CLpro transfected A549 cells
compared to the EGFP-transfected and C145A-transfected
A549 cells by an analysis of covariance (p = 0.0204 and
0.0236 respectively).
Involvement of NF-B in 3CLpro-mediated GM-CSF
expression in A549 cells
To investigate whether ERK1/2, p38, and JNK MAPK
pathways and NF-B were involved in 3CLpro-mediated
GM-CSF production in A549 cells [25,26], we examined
the expression levels of these MAP kinases and NF-B
by western blot analysis. As shown in Figure 6 (a bar
graph including mean and standard deviation were pro-
vided in Additional File 1), the expression of NF-B was
reduced in 3CLpro transfected cells at 48 hrs after trans-
fection compared to cells transfected with EGFP. In
contrast, over expression of 3CLpro did not change the
expression levels of ERK1/2, p38, and JNK in A549 cells
significantly.
Discussion
Severe acute respiratory syndrome coronavirus (SARS-
CoV) causes a severe lung infection [18-20]. It is impor-
tant to elucidate the mechanism of the lung fibrosis
caused by SARS-CoV. The expression of 3CLpro and
C145A in A549 cells was established (Figures 2 and 3) to
elucidate the pathogenesis of SARS-CoV in lung epithe-
lial cells. The localization patterns of 3CLpro and C145A
were observed both in the cytoplasm and nucleus of
A549 cells by immunofluorescence (Figure 3). Decreased
expression and levels of GM-CSF were found in 3CLpro-
transfected cells using RT-PCR, but not in C145A trans-
fected cells (Figure 2A). Down-regulation of GM-CSF
expression by 3CLpro in A549 cells may be attributed in
part to the reduced protein level of NF-kB (Figure 6). In
addition, there were no significant decreases in the
mRNA expression of IL-1b, IL-6, IL-8, IL12p40, TNF-a,
TGF-b using RT-MPCR. This finding is consistent with
that of Ziegler et al [27] who reported no induction of
cytokines genes (IFN-a, IFN-b, IL-28, IL-29, TNF-a,
CCLl5 or CXCL10) or IFN-a/b-induced MxA gene in
SARS-CoV-infected A549 cells.
GM-CSF was originally defined by its ability to gener-
ate in vitro granulocyte and macrophage colonies from
Figure 3 Nuclear and cytoplasmic localization of 3CLpro and
C145A in transfected A549 cells. EGFP, 3CLpro, and C145A
transfected A549 cells were collected at 24 hrs after transfection.
Cells were fixed and stained as described in Methods. Nuclei were
stained with DAPI (blue fluorescence, obtained from the excitation
of 359 nm and emission of 468 nm.). GFP panel shows the green
fluorescence obtained from the excitation of 488 nm and emission
of 509 nm. 3CLpro and C145A were detected with a rhodamine-
conjugated secondary antibody (red fluorescence, obtained from
the excitation of 496 nm and emission of 520 nm).
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bone marrow precursor cells [28]. Apart from its phy-
siological role in the control of alveolar macrophage
development, it now appears more likely that its major
role lies in its ability to govern the properties of the
more mature myeloid cells of the granulocyte and
macrophage lineages, particularly during host defense
and inflammatory reactions. Recent evidence for the key
role of GM-CSF in inflammatory and autoimmune dis-
eases is summarized [29]. GM-CSF-deficient mice
showed an increased susceptibility to pulmonary infec-
tions [30,31]. In addition, some studies also demon-
strated that impaired production of GM-CSF played a
Figure 4 Expression of various cytokines and chemokines in 3CLpro transfected A549 cells using RT-PCR. (A) Total RNAs were harvested
at 12, 24, 48 and 72 hrs. RT-PCR was performed to detect the expression of various cytokines and chemokines including IL-1b (343 bp), IL-6 (403
bp), IL-8 (471 bp), IL12p40 (239 bp), TNF-a (288 bp), TGF-b (148 bp), GM-CSF (195 bp). GAPDH was used as control. A549 cells were used as the
background. (B) Expression of GM-CSF in 3CLpro transfected A549 cells using RT-PCR. Total RNA was harvested at 6, 12, 24, 48 and 72 hrs. RT-PCR
was performed to detect the mRNA expression of GM-CSF (277 bp). GAPDH was used to normalize the cell number (307 bp). There were
marked decreases of GM-CSF in 3CLpro transfected A549 cells after 24 hrs (*; p < 0.05). A549 cells were used as the background. C, A549 cells; E,
EGFP transfected cells; 3CLpro, 3CLpro transfected cells.
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role in the development of bleomycin-induced pulmon-
ary fibrosis [32,33]. Together, there is growing evidence
suggesting that GM-CSF is an important regulator of
the alveolar epithelium, surfactant homeostasis, and
lung host defense [31,34]. To support the above, our
experimental results show decreased expression and
secretion of GM-CSF in 3CLpro-transfected cells, and
suggest that SARS-3CLpro will affect host defense.
Due to the functional importance of SARS-CoV
3CLpro in proteolytic recognition and processing of the
virus polyproteins, the experimental approaches and
computational prediction of substrate cleavage sites of
3CLpro become attractive topics in anti-SARS drug
design [8-11,15,35]. It is clear that the 3CLpro cleavage
sites are consistent preferentially with relative position
of P1’-Ser/Ala P1-Gln P2-Leu [35,36]. In this study,
3CLpro transfected A549 cells decreased the protein
levels of NF-kB with subsequent decline in GM-CSF
mRNA and protein expression (Figures 4-6). The amino
acid sequence analyses of NF-kB indicated that non-
canonical 3CLpro cleavage sites (such as P1’-Tyr/Gln/
Arg/Ile P1-Gln P2-Leu) commonly existed in NF-kB.
Interestingly, NF-kB are associated in GM-CSF produc-
tion in lung cancer cell lines [37]. In depth investiga-
tions are required to determine whether 3CLpro directly
or indirectly affects the protein levels of NF-kB in trans-
fected A549 cell.
Conclusions
The role of the viral cytopathic effect in the pathogen-
esis of SARS-CoV-associated lung diseases involvement
remains unclear. Our results reveals that the 3CLpro
-induced decreased GM-CSF herein may provide further
information on the pathogenesis of lung diseases with
associated SARS-CoV. Also, the protein levels of NF-kB
decreased in 3CLpro transfected cells. Thus, we conclude
that 3CLpro may mediate down-regulation of NF-kB pro-
duction and subsequently suppress GM-CSF mRNA and
protein expression in transfected A549 cells. Therefore,
the SARS-CoV 3CLpro may play a role in the mechan-




Plasmid pEGFP-C3 was obtained from CLONTECH
(CLONTECH Laboratories, Palo Alto, CA, USA). This
plasmid contains the EGFP variant and neomycin resis-
tant genes under the control of the cytomegalovirus
early gene promoter and the SV40 early gene promoter,
respectively. Full-length 3CLpro versions (wild type and
mutant, C145A) and CMV promoter were amplified by
PCR using primers containing suitable restriction sites
for subcloning into the pEGFP-C3 vector (3CLpro pri-
mers: 5’ ATATGGTACCAgTGGTTTTAGGAAAATG
GCATTC 3’/Kpn I, 5’ GAGATGAGTTTCTGCTCTTG
GAAGGTAACACCAGAGCATT 3’, and ATATGGATC
CCAGATCCTCTTCTGAGATGAGTTTCTGCTCTTG-
GAA 3’/BamH I; CMV promoter primers: 5’ ATA
TCTCGAGTAGTTATTAATAGTAATCAATTAC 3’/
XhoI and 5’ ATATAAGCTTTAGCGCTAGCGGAT
CTGA 3’/Hind III). The PCR was performed with
reagents containing a 0.2 μM primers mixture, 1.25 μM
dNTP mixture, 1.5 μM MgCl2, 10 ng templates, and
2.5 U DNA polymerase (Takara, Tokyo, Japan). Ampli-
fied DNA fragments were then ligated into the cloning




















Figure 5 Decreased secretion of GM-CSF in SARS-CoV-3CLpro
transfected cells. A549 cells were transfected with EGFP or 3CLpro
or C145A plasmids. The supernatants were collected from cell
cultures at 6, 12, 24, 48 and 72 hrs and ELISA was performed to
evaluate the amount of secreted GM-CSF. The supernatant from the
cell culture of A549 cells was used as a control. A significant
decrease of GM-CSF was observed in 3CLpro or C145A transfected
A549 cells (p = 0.0204 and 0.0236 respectively).
Figure 6 Expression of NF-kB and MAPKs in EGFP, 3CLpro, and
C145A tranfected A549 cells. A549 cells tranfected with EGFP,
3CLpro, and C145A were harvested at 24 and 48 hrs as indicated
above and total cell lysate were resolved in 12.5% SDS-PAGE.
Antibodies used in western blotting are indicated in left panel.
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into Escherichia coli DH5a competent cells, which were
obtained from Life Technologies (Carlsbad, California,
USA). Restriction enzyme digestion, PCR and DNA
sequencing analysis (Mission Biotech, Taipei, Taiwan)
were used to verify the plasmids.
Cell culture and Transfection
The human lung carcinoma A549 cells were obtained
from American type culture collection (ATCC) (Mana-
ssas, VA, USA) and were grown in Dulbecco’s modified
Eagle medium (DMEM) supplemented with 10% fetal
bovine serum (FBS) (GIBCO-BRL, Carlsbad, California,
USA) at 37°C in a 5% CO2 incubator. A total of 1 × 10
6
cells were grown to 70% confluence in 100 mm2 culture
plates before transfection. The transfection reaction was
performed by using Lipofectamine plus reagents (Invi-
trogen, California, USA) with 2 μg of each plasmid,
pEGFP-C3, pEGFP-3CLpro, and pEGFP-C145A accord-
ing to the manufacturer’s instructions. The cells were
then cultured in serum-free DMEM for 12 hrs at 37°C
in a 5% CO2 incubator and subsequently in DMEM
with 10% FBS.
Immunofluorescence cell staining and Fluorescence
Microscopy
EGFP, 3CLpro and C145A transfected A549 cells were
cultured on sterile cover slides for overnight and fixed
by methanol. Samples were blocked with 10% blocking
serum and incubated with 3CLpro antibody (Abcam Inc.,
Cambridge, MA) and rhodamine conjugated second
antibody (Invitrogen Corporation; Grand Island, NY)
separately. Nuclei were stained with DAPI (4’,6-diami-
dino-2-phenylindole, Sigma, St. Louis, MO). All trans-
fected A549 cells were observed with a Zeiss Axioplan-2
epifluorescence microscope equipped with appropriate
fluorescence filters. Digital images of the cells were
recorded by using a spot camera system.
mRNA analysis and RT-MPCR
All studies were carried out in a designated PCR-clean
area. After treatments at 12-72 hrs, cell pellets were
washed in DPBS twice and treated with Trizol mRNA
lysis buffer for total RNA extraction. All samples were
analyzed by reverse transcriptase Multiplex PCR (RT-
MPCR) with messageScreenTM Human Inflammatory
Cytokine Set 1 Multiplex PCR kits (Biosource, Interna-
tional, Inc., CA, USA) for a temporal and spatial distri-
bution of mRNA expression of different cytokines. This
method is an accurate and valid system to detect multi-
ple gene expression by amplifying all the genes under
the same conditions. The PCR derived DNA fragments,
obtained by 25 PCR cycles, and was subjected to elec-
trophoresis in a 1.7% agarose gel. The cDNAs encoding
human granulocyte-macrophage-colony-stimulating
factor (GM-CSF) and GAPDH were amplified by RT-
PCR using the following primer pairs: 5’-TGAGTAGA-
GACACTGCTGCTG-3’ (forward primer for GM-CSF
cDNAs), 5’-TCAAAGGGGATGACAAGCAGAA-3’
(reverse primer for GM-CSF cDNAs), 5’-CATGTTCGT-
CATGGGTGTGA-3’ (forward primer for GAPDH
cDNAs), and 5’-AGTGAGCTTCCCGTTCAGCTC-3’
(reverse primer for GAPDH cDNAs). The amplification
was performed in a 50 μl reaction volume containing 1×
reaction buffer (Promega, Madison, Wisconsin, USA),
1.5 μM of MgCl2, 200 μM of dNTPs, 1 μM of each pri-
mer and 2.5 units of Taq DNA polymerase (Promega,
Madison, Wisconsin, USA) using a Perkin-Elmer Gene
Amp PCR system 2400. Each cycle consists of denatura-
tion at 95°C for 1 min, annealing at 55°C for 45 sec, and
amplification at 72°C for 45 sec. The RT-PCR derived
DNA fragments obtained by 30 PCR cycles were sub-
jected to electrophoresis on a 1.7% agarose gel. Follow-
ing staining with ethidium bromide, the gels were
photographed and band intensity was measured under
UV light using the Alphaimager 2200 (Alphalnnotech,
San Leandro, CA, USA). The specific RNA level of every
sample was expressed as the product’s intensity. cDNA
encoding glyceraldehyde- 3-phosphate dehydrogenase
(GAPDH) was quantified and used to normalize the
expression of GA-CSF and each cytokine for each
sample.
Cytokine ELISA
The quantification of cytokine levels from the cell cul-
ture mediums was performed by duplication using
ELISA kits for GM-CSF (Biosource International, Inc,
CA, USA), according to the manufacturer’s instructions.
In each case, the optical density of known standards was
used to construct a calibration curve and the mean cyto-
kine values ± SD were then calculated for each sample.
Statistical analysis
Statistical analysis was performed using the paired t-test.
A P value less than 0.05 was considered significant.
GraphPad Prism software v5.01 (GraphPad Software
Inc., USA) was employed for the analysis of covariance
by comparing linear regression lines. Because the slopes
differ so much, it is not possible to test whether the
intercepts differ significantly.
2-DE
The 2-DE procedure was performed as described else-
where with minor modification [38]. Briefly, 100 μg of
protein was loaded onto IPG strips (18 cm, pH 3-10, GE
Healthcare) for analytic 2-DE analysis. The IPG strips
were subsequently rehydrated on the IPGphor IEF sys-
tem (GE Healthcare, Uppsala, Sweden) at 20°C and
30 V for 14 h. Subsequently, IEF was conducted at
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8000 V for 56 kVh for analytic analysis. Strips were then
treated with equilibration buffer containing dithiothrei-
tol (Sigma, St. Louis, MO) and then alkylated with
iodoacetate (Sigma, St. Louis, MO) for 15 min. The IPG
strips were transferred onto 10-18% linear gradient poly-
acrylamide gels (18×18 cm) and the electrophoresis was
performed at 45 mA per gel at 4°C.
Western blot
Proteins that had been resolved on 12.5% SDS-PAGE
or 2-DE gels were electroblotted onto PVDF mem-
branes using a semi-dry apparatus (GE Healthcare,
Uppsala, Sweden). The membranes were blocked for
1 h with 5% non-fat milk and 0.1% Tween-20 in PBS,
followed by incubation with primary antibody (3CLpro,
NF-kB, ERK1/2, JNK, p38, GAPDH, Abcam Inc., Cam-
bridge, MA) for 2 h at room temperature. After wash-
ing three times with PBS containing 0.05% Tween-20
(PBST), the primary antibody was detected with an
anti-rabbit horseradish peroxidase-conjugated second-
ary antibody (Abcam Inc., Cambridge, MA) for 1 h at
room temperature. Signals were developed with an
enhanced chemiluminescence western blotting detec-
tion system (PerkinElmer, Boston, MA,).
Additional material
Additional file 1: A bar graph of NF-kB and MAPKs expression in
EGFP, 3CLpro, and C145A tranfected A549 cells. The relative
expression level of NF-kB and MAPKs in EGFP, 3CLpro, and C145A
tranfected A549 cells at 24 and 48 hrs in Figure 6 are compared with
GAPDH and depicted in the bar graph including mean and standard
deviation.
List of abbreviations
SARS-CoV: Severe acute respiratory syndrome coronavirus; 3CLpro: 3C-like
protease; GM-CSF: human granulocyte macrophage colony stimulating
factor; ELISA: Enzyme-linked immunosorbent assay; RT-PCR: reverse
transcription polymerase chain reaction; IL-1β: interleukin 1 beta; IL-6:
interleukin 6; IL-8: interleukin 8; TNFα: tumour necrosis factor α; IL-12p40:
interleukin 12 p40 subunit; TGF-β: transforming growth factor β; ERK1/2:
extracellular-signal-regulated kinases 1 and 2; NF-kB: nuclear factor kappa B;
JNK: c-Jun N-terminal kinases; p38 MAPK: P38 mitogen-activated protein
kinases; EGFP: enhanced green fluorescent protein; GAPDH: Glyceraldehyde
3-phosphate dehydrogenase.
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